Source link : https://www.newshealth.biz/health-news/fda-approves-first-drug-for-mash/
The US Food and Drug Administration (FDA) has approved resmetirom (Rezdiffra, Madrigal Pharmaceuticals), the first drug to treat patients with metabolic dysfunction–associated steatohepatitis (MASH) and moderate to advanced liver fibrosis (consistent with stage F2 and F3 disease), along with diet and exercise. Resmetirom is a once-daily, oral thyroid hormone receptor beta-selective agonist. The FDA granted […]
Author : News Health
Publish date : 2024-03-14 21:15:11
Copyright for syndicated content belongs to the linked Source.
in Health